Linking hydroxychloroquine to hemolysis in a ‘suspected’ glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection – a critical appraisal-Reference-Cited by-同舟云学术

Linking hydroxychloroquine to hemolysis in a ‘suspected’ glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection – a critical appraisal

Published:2020-10 Issue: Volume:80 Page:101-102
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Afra T.P.,Nampoothiri Ram Vasudevan,Razmi T Muhammed^ORCID,Hafi N. A. Bishurul

Publisher

Elsevier BV

Subject

Internal Medicine

Reference10 articles.

1. Acute hemolysis by hydroxycloroquine was observed in G6PD-deficient patient with severe COVD-19 related lung injury;De Franceschi;Eur J Intern Med,2020

2. Hydroxychloroquine use in COVID-19: what is the basis for baseline tests?;Afra;Lancet Infect Dis,2020

3. Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review;Youngster;Drug Saf,2010

4. Examination of hydroxychloroquine use and hemolytic anemia in G6PDH-deficient patients;Mohammad;Arthritis Care Res (Hoboken),2018

5. The haematological consequences of plasmodium vivax malaria after chloroquine treatment with and without primaquine: a worldwide antimalarial resistance network systematic review and individual patient data meta-analysis;Commons;BMC Med,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Affinity of Hemoglobin for Oxygen Is Not Altered During COVID-19;Frontiers in Physiology;2021-04-12

2. COVID-19 may enhance risk of thrombosis and hemolysis in the G6PD deficient patients;Nucleosides, Nucleotides & Nucleic Acids;2021-03-15

3. Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: New case reports coming out;European Journal of Internal Medicine;2020-10

4. Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection;Expert Review of Anti-infective Therapy;2020-08-16